Literature DB >> 23445932

[Pyschotherapygenetics. Do genes influence psychotherapy adherence?].

Víctor Pérez1, Juan Carlos Pascual, Joaquim Soler, Thais Tiana, Anna Cortés, Montserrat Baiget, Ana Martín-Blanco, Enrique Alvarez.   

Abstract

OBJECTIVE: There is probably an association between genetic factors, personality traits and response to psychotherapy. We propose the new concept of "psychotherapygenetics" as a strategy to study how genetic factors may influence psychotherapeutic response. The aim was to examine the association between polymorphisms of the serotonin transporter gene (SERT) and the dopamine 4-receptor gene (DRD4) with adherence to psychotherapy.
METHOD: We performed a prospective study of 110 patients with borderline personality disorder (BPD) who participated in dialectical behavioral therapy (DBT). Three polymorphisms were examined: the 5-HTTLPR and the VNTR on the SERT gene and the 7-repeat allele (D4.7) on the DRD4 gene. The dropout rate and the mean number of sessions attended were used as an adherence index.
RESULTS: The presence of the 12-repeat allele on the VNTR polymorphism of SERT was associated with higher adherence to psychotherapy. There was no significant association between the 5-HTTLPR or D4.7 polymorphisms and adherence.
CONCLUSIONS: Our preliminary results show a correlation between certain genetic variations and adherence to DBT in patients with BPD. A "psychotherapygenetics" approach could be useful to study how genetic variables may influence patients' psychotherapy response.
Copyright © 2009 SEP y SEPB. Published by Elsevier Espana. All rights reserved.

Entities:  

Year:  2010        PMID: 23445932     DOI: 10.1016/j.rpsm.2010.03.003

Source DB:  PubMed          Journal:  Rev Psiquiatr Salud Ment        ISSN: 1888-9891            Impact factor:   3.318


  1 in total

Review 1.  Neural Changes in Borderline Personality Disorder After Dialectical Behavior Therapy-A Review.

Authors:  Adam Iskric; Emily Barkley-Levenson
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.